Author/Authors :
Nasr Esfahani, Parisa Students’ Research Center - School of Medicine - Isfahan University of Medical Sciences, Isfahan , Nasiri, Jafar Child Growth and Development Research Center - Research Institute for Primordial Prevention of Noncommunicable Disease - Isfahan University of Medical Sciences, Isfahan , Badihian, Shervin Students’ Research Center - School of Medicine - Isfahan University of Medical Sciences, Isfahan , Yaghini, Omid Child Growth and Development Research Center - Research Institute for Primordial Prevention of Noncommunicable Disease - Isfahan University of Medical Sciences, Isfahan
Abstract :
Objectives
Considering the common use of valproate among children, we investigated the
short-term side-effects of low dose valproate monotherapy in epileptic children.
Methods
In this prospective study, 209 epileptic children (48.3% male, mean age:
7.02 ± 3.13 yr) on low therapeutic dose of valproate monotherapy (20-30
mg/kg/d) were enrolled during 2014-2015 in Isfahan Pediatric Neurology
Clinic, Isfahan University of Medical Sciences, Isfahan, Iran and sideeffects
were evaluated through frequent clinical visits and laboratory tests
during 6 months of valproate therapy.
Results
Weight gain was reported in 53.1% of patients. Decreased appetite was seen
in 11% of patients, more frequent in younger cases (P=0.006). Abdominal
pain, nausea/vomiting, diarrhea, and constipation were reported in 16.3%,
2.4%, 1.4%, and 1% of patients, respectively. Headache, tremor, dizziness,
abnormal color vision, myoclonus, and bruxism were seen in 5.7%, 1.4%,
1%, 1%, 1%, and 0.5% of patients, respectively. Enuresis, hair loss, and
skin rash were reported in 8.1%, 6.7%, and 0.5% of patients, respectively.
Thrombocytopenia, impaired liver function tests, and leukopenia occurred
in 1%, 1%, and 0.5% of patients, respectively.
Conclusion
Low dose valproate monotherapy may cause numerous side-effects,
mostly not life-threatening and requiring no action. Beside other reported
complications, we observed decreased appetite (among younger patients),
enuresis, and abnormal color vision which are only briefly discussed in the
literature and need to be addressed more.
Keywords :
Adverse drug reactions , Epilepsy , Pediatrics , Valproate monotherapy